JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M112139200 on January 30, 2002

J. Biol. Chem., Vol. 277, Issue 14, 11765-11771, April 5, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/14/11765    most recent
M112139200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiapperino, D.
Right arrow Articles by Cheh, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiapperino, D.
Right arrow Articles by Cheh, A. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Preferential Misincorporation of Purine Nucleotides by Human DNA Polymerase eta  Opposite Benzo[a]pyrene 7,8-Diol 9,10-Epoxide Deoxyguanosine Adducts*

Dominic ChiapperinoDagger , Heiko KrothDagger , Irene H. KramarczukDagger §, Jane M. SayerDagger , Chikahide Masutani, Fumio Hanaoka||, Donald M. JerinaDagger , and Albert M. ChehDagger §**

From the Dagger  Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, Bethesda, Maryland 20892, the § Department of Chemistry, American University, Washington, D. C. 20016, || RIKEN and Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Wako, Saitama 351-0198, Japan, and the  Institute for Molecular and Cellular Biology, Osaka University, Suita, Osaka 565-0871, Japan

Received for publication, December 19, 2001, and in revised form, January 23, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Human DNA polymerase eta  was used to copy four stereoisomeric deoxyguanosine (dG) adducts derived from benzo[a]pyrene 7,8-diol 9,10-epoxide (diastereomer with the 7-hydroxyl group and epoxide oxygen trans (BaP DE-2)). The adducts, formed by either cis or trans epoxide ring opening of each enantiomer of BaP DE-2 by N2 of dG, were placed at the fourth nucleotide from the 5'-end in two 16-mer sequence contexts, 5'~CG*A~ and 5'~GG*T. poleta was remarkably error prone at all four diol epoxide adducts, preferring to misincorporate G and A at frequencies 3- to more than 50-fold greater than the frequencies for T or the correct C, although the highest rates were 60-fold below the rate of incorporation of C opposite a non-adducted G. Anti to syn rotation of the adducted base, consistent with previous NMR data for a BaP DE-2 dG adduct placed just beyond a primer terminus, provides a rationale for preferring purine misincorporation. Extension of purine misincorporations occurred preferentially, but extension beyond the adduct site was weak with Vmax/Km values generally 10-fold less than for misincorporation. Mostly A was incorporated opposite (+)-BaP DE-2 dG adducts, which correlates with published observations that G right-arrow T is the most common type of mutation that (+)-BaP DE-2 induces in mammalian cells.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Somatic mutation of proto-oncogenes and tumor suppressor genes is a key component in the initiation of cancer (1). Any DNA damage that escapes repair could lead to mutations. However, replicative DNA polymerases are blocked in a potentially lethal manner when they encounter bulky adducts (2). Thus, they are unable to convert adducts to mutations. Recently, a growing number of DNA polymerases capable of conducting translesion DNA synthesis have been discovered (3-11); these likely hold the key to mutagenesis and the initiation of cancer induced by bulky adducts. One of these lesion-bypassing DNA polymerases, human DNA polymerase eta (poleta )1 (12, 13) is a member of the UmuC/DinB/Rev1/Rad30 superfamily (now called the Y family (14)) of DNA polymerases. In humans it is a product of the XPV skin cancer susceptibility gene; inactivation of poleta results in a variant form of xeroderma pigmentosum (12, 15). poleta incorporates mostly correctly at cis-syn T-T cyclobutane dimers (16, 17), N-(deoxyguanosin-8-yl)-acetylaminofluorene (18), and cis-Pt G-G adducts (18, 19); small amounts of incorrect nucleotides are also incorporated, mostly at the level seen with undamaged DNA. With (6-4) T-T photoproducts, however, a single G is preferentially incorporated (20).

Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental carcinogens (21). Bay-region diol epoxides, formed on an angular benzo-ring, have been shown to be the ultimate carcinogenic metabolites of the PAHs (21-25). Four optically active bay-region diol epoxide isomers (enantiomers of a pair of diastereomers) are formed metabolically from a given hydrocarbon. In the DE-1 ("syn") diastereomer, the epoxide oxygen and benzylic 7-hydroxyl groups are cis, whereas in the DE-2 ("anti") diastereomer these groups are trans (see Fig. 1A below). For bay-region diol epoxides, the DE-2 isomer with R,S,S,R absolute configuration exhibits by far the greatest carcinogenicity compared with the other three optically active isomers, whereas for fjord-region diol epoxides significant carcinogenic activity is not limited to this isomer (26).

The exocyclic amino groups of purine bases (N2 of G and N6 of A) in DNA are the principal targets of PAH diol epoxides (27). Cis and trans addition of the amino group to the benzylic epoxide position of the diol epoxide produces adducts that have either retained or inverted configuration, respectively, at the point of attachment (C-10 for benzo[a]pyrene) to the hydrocarbon moiety. Fig. 1B shows how cis addition at C-10 of (+)-(7R,8S,9S,10R)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene ((+)-BaP DE-2) results in retention of configuration at C-10 (10R right-arrow 10R) whereas trans addition results in inversion of configuration (10R right-arrow 10S).

The present study utilizes N2 dG adducts derived from the carcinogenic (+)-BaP DE-2 and the weakly carcinogenic or non-carcinogenic (26) (-)-(7S,8R,9R,10S)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene ((-)-BaP DE-2). A report (28) of poleta activity at the trans (10S) dG adduct of (+)-BaP DE-2 indicated that A and T were frequently misincorporated; however, only the 10S adduct was investigated. In the present study we report that misincorporation of purine nucleotides by poleta commonly occurs opposite all four types of dG adducts (cis/trans and 10R/10S) formed by carcinogenic (+)-BaP DE-2 and non-carcinogenic (-)-BaP DE-2, with the adducts placed in two different DNA sequence contexts (Fig. 1C).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1.   Adducts formed by BaP DE-2 isomers. A, the two metabolically formed diastereomers of the bay-region benzo[a]pyrene diol epoxide (BaP DE). In DE-1 the benzylic 7-hydroxyl group and epoxide oxygen are cis, and in DE-2 these groups are trans. Each diastereomer consists of a pair of enantiomers. B, partial structures of the BaP DE-2 enantiomers, (+)-(7R,8S,9S,10R)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene ((+)-BaP DE-2) and (-)-(7S,8R,9R,10S)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene ((-)-BaP DE-2), are shown along with the ring-opened products formed upon their reactions with the exocyclic N2-amino group of dG (indicated as -NHR). Cis opened adducts retain configuration at C-10, whereas trans adducts have inverted configuration. C, the DNA 16-mers, contexts III(G) and IV(G), used as templates in the present study. The adduct is indicated as G*.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Oligonucleotides-- Oligonucleotides containing a single specific cis or trans BaP DE-2 dG adduct placed on the fourth nucleotide from the 5'-end in either sequence context III(G) (5'-TTCG*AATCCTTCCCCC-3') or IV(G) (5'-GGGG*TTCCCGAGCGGC-3') were synthesized as described previously (29, 30). The basis for selection of these sequences has been described previously (30). Polyacrylamide gel-purified, non-adducted oligomers were purchased from either Lofstrand Laboratories Limited (Gaithersburg, MD) or Midland Certified Reagent Co. (Midland, TX) and were purified further by reverse-phase high performance liquid chromatography if necessary.

DNA Polymerase eta  Reactions-- His-tagged recombinant DNA polymerase eta  was produced as described previously (18). Polymerase reactions contained final concentrations of 40 mM Tris-HCl (pH 8.0), 1 mM MgCl2, various concentrations of the four dNTPs, 10 mM dithiothreitol, 250 µg/ml bovine serum albumin, 60 mM KCl, 2.5% glycerol, 40 nM 5'-32P-labeled primer previously annealed to 60 nM 16-mer template (by heating at 95 °C for 5 min, and slowly cooling), and 2 nM DNA polymerase eta  in a 10-µl volume. Reactions proceeded at 37 °C for 3-15 min. Reactions were stopped by addition of 10 µl of 90% aqueous formamide containing EDTA (25 mM) and gel sequencing dye solution, followed by heating in a boiling water bath.

Kinetic Analysis of Incorporation-- Reaction products were subjected to electrophoresis on 20% polyacrylamide-7 M urea gels run at 60 watts. After drying the gels, the extent of incorporation was quantitated with a Fujifilm Fluorescent Image Analyzer and Image Gauge V3.12 software. Steady-state kinetic experiments followed the procedures of Creighton et al. (31) whereby maximum incorporation is kept below 20%. Rectangular hyperbolic fits yielding apparent Vmax and Km values were calculated using SigmaPlot 2000. Relative values of Vmax/Km for incorrect versus correct nucleotide incorporation were used to calculate the misincorporation efficiency (finc).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Misincorporation on the Non-adducted Sequence Context III(G) DNA Template-- Previous studies of poleta have used templates that ranged from 30 to 75 bases in length (17, 18, 28, 32). We first examined our shorter context III(G) 16-mer template to determine its efficacy as a substrate. In standing start assays with a 12-mer primer, non-adducted 16-mer template of context III(G) DNA (12/16 DNA) and dCTP at 1 mM concentration, the primer was mostly extended by one nucleotide (Fig. 2A). When all four dNTPs were present at 1 mM further extension occurred, with limited procession to the end of the template (Fig. 2A). Misincorporation efficiencies (finc) were measured in standing start, steady-state kinetic assays. Table I shows similar misincorporation efficiencies of around 2 × 10-3 for all three incorrect nucleotides. These misincorporation efficiencies are somewhat lower than those reported by Johnson et al. (17) for the three nucleotides and Matsuda et al. (32) for G. Matching finc values are not expected because of differences in assay conditions and templates. However, observation of misincorporation frequencies that fall within the range of 10-2 to 10-3 previously observed for poleta increases our confidence that correct finc values are likely to be obtained from kinetic studies with 12/16 oligomers containing adducts at the fourth nucleotide (dG) from the 5'-end of the 16-mer template.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2.   Patterns of dNTP incorporation across from BaP DE-2 dG adducts in context III(G). For the template sequence and adduct structures see Fig. 1. A, gel showing incorporation opposite the fourth nucleotide (G) from the 5'-end of the template strand in the absence of adduct. 0, control with no dNTP; 4, incorporation in the presence of all four dNTPs (1 mM each); the other lanes show incorporation with the individual dNTPs (1 mM) as indicated. B, gels showing incorporation opposite BaP DE-2 dG adducts in the same position as in A. Labeling of the lanes is as in A; each dNTP is present at 0.2 mM.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Frequency of poleta misincorporation at non-adducted G

Patterns of Incorporation in Sequence Context III(G) with BaP DE-2 dG Adducts-- Fig. 2B shows dNTP incorporation across from each of the four stereoisomeric BaP DE-2 dG adducts, compared with the non-adducted template. Assays were performed with 0.2 mM dNTP concentrations. It is clear that when any one of the stereoisomeric BaP DE-2 adducts is present, purine nucleotides are incorporated far more than either T or the correct C. Misincorporation of A is most extensive with the trans S adduct.

For each dNTP, more incorporation is seen with the trans-ring opened adducts compared with the cis adducts with the same R or S configuration at C-10. Less purine misincorporation occurs at cis adducts than trans adducts, particularly the cis S adduct, but incorporation of the correct C is also lower. Incorporation at cis R adducts formed from the carcinogenic (+)-BaP DE-2 is greater than incorporation at cis S adducts formed from the non-carcinogenic (-)-BaP DE-2.

The results shown in Fig. 2B for the BaP DE-2 trans S adduct agree with those obtained by Zhang et al. (28), who examined only this adduct, in that A is incorporated the best, but differ significantly in that we observed much higher G incorporation and much lower T incorporation. Differences between the assays, such as DNA sequence context or assay buffer composition and pH, could underlie the differences.

Kinetics of Misincorporation at BaP DE-2 dG Adducts in Sequence Context III(G)-- Table II shows Vmax/Km data for incorporation of individual nucleotides by poleta opposite BaP DE-2 dG adducts in sequence context III(G). In the presence of these adducts, the highest Vmax/Km values observed are about two orders of magnitude lower than the Vmax/Km for incorporation of the correct C at non-adducted G (Table I). The adducts constitute a fairly strong block to the enzymatic activity of poleta . Notably, however, the adducts have a blocking effect only on incorporation of a correct C, whereas incorrect base incorporation is either changed very little or actually enhanced in the presence of adducts. Thus, the presence of an adduct lowers Vmax/Km for C incorporation by factors of 1600 to more than 18,000 whereas Vmax/Km for T incorporation decreases by 2.2- to 16-fold, G incorporation rises up to 3-fold and A incorporation rises 1.5- to 7.4-fold.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Fidelity of poleta at BaP DE-2 adducts in sequence context III(G)
For template sequence see Figure 1C.

Typical kinetic data for the trans S dG adduct are shown in Fig. 3. For all four adducts, incorporation of the correct C is the lowest of the four dNTPs. In the assays, there is evidence for inhibition by dNTP concentrations greater than 2 mM, which limits the amount of dCTP that can be used to increase incorporation. This makes it difficult to determine a precise Vmax/Km value for C incorporation at cis S adducts and precise finc values for G, A, and T misincorporation. Still, it is clear that incorporation of purines far exceeds that of pyrimidines opposite all four adducts in sequence context III(G). The preference for G misincorporation over correct incorporation of C ranges from 5.5-fold to more than 50-fold, whereas the preference for A over C ranges from 20-fold to more than 50-fold.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 3.   Kinetics of dNTP incorporation across from 10S trans-ring opened BaP DE-2 dG adducts in sequence context III(G). A, gels showing incorporation with 0, 20, 50, 100, 200, 500, and 1000 µM dGTP (lanes 1-7); 0, 5, 10, 20, 50, 100, and 200 µM dATP (lanes 8-14); 0, 50, 100, 200, 500, 1000, and 2000 µM dTTP (lanes 15-21) and dCTP (lanes 22-28). B, hyperbolic Michaelis-Menten plots of the rates of incorporation using the data obtained from A; units of Vmax/Km are as in Table II.

With all four dNTPs, Vmax/Km values for purine and T misincorporation are generally greater for trans ring-opened adducts than cis ring-opened adducts, whether comparing the pairs trans R versus cis R or trans S versus cis S (members of each pair derived from opposite enantiomers of the diol epoxide) or the pairs trans R versus cis S or trans S versus cis R (members of each pair derived from the same diol epoxide enantiomer so that the configuration differs only at C-10). Vmax/Km values for A, T, and C incorporation are greatest at trans S adducts, whereas Vmax/Km for G incorporation is greatest at trans R adducts. The overall rate of incorporation (sum of Vmax/Km values) follows the pattern trans R >=  trans S >=  cis R cis S. Values of finc for A and G, however, are much greater for cis adducts than trans adducts, because of far lower incorporation of C at cis adducts. Values of finc for G versus A are similar with all of the adducts except trans S, whose finc for A is four times larger than finc for G.

Kinetic Comparisons of Incorporation Across from BaP DE-2 dG Adducts in Sequence Contexts III(G) and IV(G)-- Preferential incorporation of purine nucleotides over pyrimidine nucleotides is seen with both sequence contexts III(G) (5'~CG*A~) (Table II) and IV(G) (5'~GG*T~) (Table III). But, except for the trans S isomer, the Vmax/Km for misincorporation is far lower and Vmax/Km for C is unchanged or higher, with the result that finc values are far lower in context IV(G). This is particularly so with the cis isomers. With the trans R, cis R and cis S isomers, the decreased preference for purine misincorporation is due to the decline in Vmax/Km values in context IV(G) compared with context III(G) being greater for the purines than the pyrimidines. With the change in sequence context, the Vmax/Km values for purine misincorporation drop an order of magnitude for trans R and cis R adducts and 3- to 5-fold for cis S adducts. With trans S adducts, Vmax/Km values are greater in sequence context IV(G), substantially so with G and T incorporation. At the same time, when the sequence is changed to IV(G), C incorporation efficiency declines only 4-fold for trans R adducts and either stays about the same or rises for the other three adducts. Consequently, A incorporation at trans S adducts has the highest efficiency of misincorporation (finc) of all.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Fidelity of poleta at BaP DE-2 adducts in sequence context IV(G)
For template sequence see Figure 1C.

Patterns emerge from trans versus cis comparisons of Vmax/Km values for incorporation in sequence context IV(G) that are like the ones seen in sequence context III(G). Vmax/Km values for purine misincorporation are appreciably larger for trans adducts. However, because C incorporation is so different at context IV(G) adducts, finc values for G and A for trans adducts are no longer much smaller than for cis adducts, as was seen in context III(G). Patterns based on R versus S comparisons in sequence context IV(G) are not evident.

The effect of changing the sequence from III(G) to IV(G) on T misincorporation parallels the effect seen with the purines. Vmax/Km for T misincorporation is higher at trans S adducts, and lower at the other three. Combined with the aforementioned changes in C incorporation, the result is a decrease in finc for T at cis adducts, little change at trans R adducts and a rise at trans S adducts.

Kinetics of Extension of Primers Containing Correct and Incorrect Bases Opposite BaP DE-2 dG Adducts in Sequence Context III(G)-- Table IV summarizes the Vmax/Km data for extension of 13-mer primers containing either a correct C or a mispaired base opposite the adducts by incorporation of a correct G opposite the C immediately 5' to the adduct position in template sequence III(G). Data for the control, unadducted template are included for comparison. Notably, extension beyond the adducts is very inefficient, especially for both the trans adducts as well as the cis S adduct. In the absence of an adduct, extension of the correctly paired C-containing primer is favored by a factor of 30 to 100. Strikingly, however, for all but the cis R adduct, extension of mispaired primers containing a purine opposite the adduct is favored (>=  3-fold) relative to extension of primers containing the correctly paired C. Thus, once an incorrect base is inserted opposite these adducts, poleta exhibits a bias in favor of extending the mispaired primer. The cis R adduct constitutes an exception, in that extension of the correctly paired primer is substantially preferred over that of primers containing a mispair (although only 2-fold over extension of a misincorporated A), and this correct extension occurs with the highest efficiency of any of the adducts.

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Extension by poleta of (mis)pairs containing BaP DE-2 adducts in sequence context III(G)
For template sequence see Fig. 1C.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

A Mechanism for Preferential Purine Nucleotide Misincorporation Across from BaP DE-2 dG Adducts-- All four BaP DE-2 dG adducts represent significant blocks to C incorporation. In sequence context III(G), incorporation of the correct C drops as much as 20,000-fold relative to the corresponding rate in the absence of adduct. In contrast, the rates of incorporation of the purine nucleotides rise slightly (less than 10-fold compared with their rates in the absence of adduct). Consequently, the efficiency (finc) of A misincorporation at BaP DE-2 dG adducts in sequence context III(G) (Table II), relative to A misincorporation in normal DNA (Table I), jumps over four orders of magnitude from 1.8 × 10-3 to a range of 20 to over 50 times C incorporation (Table II), and the efficiency of G misincorporation jumps nearly as much.

We propose the following mechanism for preferential purine misincorporation opposite the BaP DE-2 dG adducts: 1) Stacking of the hydrocarbon with the preceding base pair causes the adducted dG to assume the unusual syn rather than the usual anti torsion angle, with the stacked hydrocarbon and the syn dG conformation being accommodated by the open poleta active site; 2) the enzyme misincorporates purine nucleotides opposite this syn dG adduct by Topal and Fresco (33) purine-purine base pairing, and 3) after purine misincorporation the adduct remains intercalated in the DNA. Evidence supporting this mechanism comes from the structural information that follows.

poleta exhibits unusually high misincorporation frequencies of 10-2 to 10-3 in normal, non-adducted DNA (17, 32). This indicates an active site whose discrimination in favor of Watson-Crick and other base pairs with similar geometry is considerably relaxed compared with many other non-proofreading polymerases but is still 100- to 1000-fold. Crystal structures for members of the Y family of DNA polymerases (34-37), including the catalytic core of poleta from yeast (35), have been reported. Although Y family polymerases have a classic DNA polymerase palm structure, the finger and thumb structures are smaller than usual. An additional structure called a polymerase-associated domain (35) or little finger (36) is present. Despite the latter, the Y-family DNA polymerase active site is more open where the incoming deoxyribonucleotide binds, and the degree of interaction with the primer-template complex is less than what is seen with high fidelity DNA polymerases. These features, which are inferred by homology modeling with T7 DNA polymerase in two studies (34, 35) and are observed directly in a third (36), could underlie the relative lack of fidelity exhibited toward non-adducted DNA, and the ability to accommodate bulky adducts attached to syn-rotated dG and incorporate a nucleotide across from such lesions (34-37).

The solution NMR structure of a BaP DE-2 trans S dG adduct bound to the fourth base from the 5'-end of a 13-mer template (5'-AACG*C~) adjacent to the terminus of a 9-mer primer strand provides a model for a partially extended DNA duplex as "seen" by a polymerase. This structure shows that prior to insertion of the complementary nucleotide, the adducted dG is rotated anti to syn to allow the hydrocarbon moiety to stack with the base pair formed by the 3'-terminal primer base and the base immediately 3' to the modified dG on the template strand (38). After a complementary C is incorporated opposite the BaP DE-2 trans S dG adduct, the adducted dG assumes the normal anti conformation and the adduct swings out into the minor groove (39). This same groove-bound, anti conformation of the adduct is maintained upon further extension of the primer chain beyond the adduct site, as is shown by the structure of a fully complementary 11-mer duplex (40) with the same local ~CG*C~ sequence around the adduct.

There are no NMR data for mismatched duplex structures corresponding to incorrect purine nucleotide insertion opposite BaP dG adducts; however, substantial UV red shifts are observed for the long-wavelength pyrene band of duplexes containing purine mismatches opposite BaP trans R and trans S dG adducts in the same ~CG*C~ context (41), from 346 nm (when C is paired with the adducted G) to around 350 nm in the G and A mispaired duplexes. These shifts are indicative of base stacking, and suggest that the hydrocarbon remains intercalated (41), with the adducted dG presumably still in the syn conformation, after an incorrect purine nucleotide is inserted opposite the adduct and the primer is further extended.

If the adducted dG is in the syn conformation before and after polymerization then presumably it is also syn when the incoming nucleotide binds and is incorporated. A syn glycosidic torsion angle of the adducted dG in the template allows purine-purine base pairing of the type proposed by Topal and Fresco (33). Molecular modeling (42) of the BaP DE-2 trans S adduct in a 13-mer template, 10-mer primer structure (the 13-mer template and 9-mer primer described above with the primer extended to include A across from the adduct) suggests that the size and shape of the (syn-adducted-G)·(anti-A) pair very much resembles that of a normal T·A pair. The 100- to 1000-fold preference for base pairs having the approximate size and shape of a Watson-Crick base pair could also cause the enzyme to select syn-adducted G paired with anti-A over pairing with the correct C. The observed red shifts (41) increase (more favorable base stacking) in the same order as the present Vmax/Km values for poleta misincorporation of purines at trans adducts.

Even though an NMR structure could not be determined (38) when the trans S dG adduct above is replaced by a trans R dG adduct, it is likely that the poleta preference for forming (adducted-G)·(purine) mispairs with the BaP trans R adduct can be explained by a mechanism similar to that described above for the trans S adduct. UV spectra of oligonucleotide duplexes containing the trans R dG adduct mispaired with purines show significant red shifts of the long wavelength absorbance (41), consistent with base stacking and syn glycosidic rotation, and are indicative of a structure analogous to that observed with the trans S dG adduct.

Structural analysis of either a cis R or cis S BaP DE-2 dG adduct placed in the same position as the trans adducts just described, either before or after a correct or incorrect incorporation of nucleotide has yet to be reported. In fully duplex DNA, the guanine base bearing either a cis R (43) or a cis S (44) BaP adduct is displaced out of the DNA helix as is its complementary C, and neither NMR nor UV studies with purine-purine mispairs of cis adducts are available. Thus no structural information exists that might explain preferential purine incorporation versus C incorporation at the present cis adducts; however, as in the case of the trans adducts, the observed preference for purine misincorporation presumably could also result from anti to syn rotation of the adducted dG and Topal and Fresco (33) base pairing.

8-Oxo-dG forms stable G·A pairs in DNA with the G rotated anti to syn (45), resulting in G to T transversions (A misincorporation) with polbeta (46). In mammalian cells, G right-arrow T transversions also commonly occur at N-(deoxyguanosin-8-yl)-acetylaminofluorene adducts depending on the DNA sequence (47) and are attributed to the adducted dG adopting a syn conformation (48). poleta , however, mostly incorporates the correct C across from these two types of C-8 G adducts (16, 49), suggestive that with these types of adducts the active site of poleta forces the G to rotate back to the anti conformation. It is interesting that this occurs with these C-8 dG adducts but not with the present BaP DE-2 N2-dG adducts.

Effect of Sequence Context on Misincorporation-- The most pronounced sequence effect seen in this study is the sharply lower set of Vmax/Km values for misincorporation observed with sequence context IV(G) (Table III) compared with sequence context III(G) (Table II), seen with all adducts except for trans S BaP DE-2. For the other adducts in sequence context IV(G), the decrease in the rate of purine misincorporation is more than an order of magnitude with the cis R adduct, about an order of magnitude with the trans R adduct and 3- to 5-fold with the cis S adduct. The Vmax/Km values for C incorporation decrease by small amounts with two of the adduct isomers and rise with the other two. The higher rate of C incorporation in sequence context IV(G) compared with context III(G) could arise from misalignment using the next 5'-template G in place of the adducted G.

With sequence context IV(G) the Vmax/Km for misincorporation of A at the trans S adduct is the largest for any nucleotide-adduct combination and is 18-fold greater than for A misincorporation at the trans R adduct. This observation is of special interest in light of the fact that the trans S is the predominant adduct formed on DNA (50) by the highly carcinogenic (+)-BaP DE-2 isomer whereas trans R is the predominant adduct formed by the weakly or non-carcinogenic (-)-BaP DE-2 isomer (26).

A significant finding of this study is that the sequence context effect on the efficiency of base misincorporation depends on the specific adduct. The present two sequences differ in both the 3'- and 5'-nearest neighbors to the adducted G. The 3'-nearest neighbor is A in sequence context III(G) and T in sequence context IV(G). Specific stacking interaction between an adduct and the preceding (3') base pair is suggested by NMR analysis (38) of a partial template·primer duplex in which the 3'-nearest neighbor to the adducted G is C (see above). Small differences in stacking geometry between the adduct and different 3'-nearest neighbor bases and their complements could account for the observed differences in misincorporation frequency between templates III(G) and IV(G). Specific effects of the 5'-nearest neighbor are also possible, such as template slippage leading to enhanced correct insertion of C with template IV(G) as mentioned above or changes in stacking depending on the identity of the 5'-base. Our observed dependence of misincorporation on sequence suggests that it will be fruitful to focus bypass studies of misincorporation on specific proto-oncogene and tumor suppressor sequences.

Mutational Spectra of BaP DE-2 dG Adducts in Mammalian DNA-- It is of considerable interest to establish what role poleta plays in determining the mutational spectrum that has been observed for PAHs in mammalian cells. The preponderant products of in vitro reaction of BaP diol epoxides with dG in DNA are trans ring-opened adducts formed at the exocyclic nitrogen of dG. Upon reaction of (-)-BaP DE-2 with calf thymus DNA in vitro, trans R and cis S dG adducts are formed in the ratio of ~6:1 (50). At both types of adduct, poleta strongly favored misincorporation of purines, with both G and A being misincorporated about equally and 5 to 20 times the rate for T misincorporation. Once purine misincorporation occurred, such mispairs were extended somewhat better than the correctly paired primers for three out of the four adducts studied in sequence III(G). However, the extension of these mispairs was still quite inefficient (Vmax/Km generally about 10- to 20-fold smaller than Vmax/Km for purine incorporation; Tables II and IV), suggesting that if purine misincorporation by poleta plays a role in mutagenesis induced by BaP DE adducts, an additional polymerase or polymerases are likely to be required for full extension of the damaged DNA to give an observed mutagenic event. Precedent for such a mechanism is provided by the observation that poliota and polzeta act sequentially to bypass abasic sites as well as the (6-4) T-T photoproduct (51).

The relative lack of T misincorporation by poleta contrasts with limited data (52) on the mutational spectrum of (-)-BaP DE-2 in the HPRT gene in Chinese hamster V-79 cells, in which G right-arrow C, G right-arrow T, and G right-arrow A mutations (misincorporation of G, A, and T, respectively) occurred to similar extents (1.5:1.0:0.8). Far more information is available about the spectrum of mutations at G produced by (+)-BaP DE-2 in mammalian cells. In the HPRT gene in V-79 cells, the relative proportions of the three possible base substitutions at G are virtually independent of dose (53). At three different doses of (+)-BaP DE-2, G right-arrow T transversions accounted for 67-75%, G right-arrow C transversions for 18-21%, and G right-arrow A transitions for 7-11% of the total mutations (53). The use of repair-deficient Chinese hamster V-H1 cells (54) resulted in little change in the relative mutational frequencies at two different doses: 60-63% of G mutations were G right-arrow T transversions, 20-23% were G right-arrow C transversions, and 15-19% were G right-arrow A transitions. These frequencies of misincorporation are consistent with our poleta results described below.

The spectrum of mutations produced in the ras proto-oncogene was determined (55) in mice whose skins were painted with the parent hydrocarbon, BaP. When forming bay-region diol epoxides from the (+)- and (-)-enantiomers of BaP 7,8-dihydrodiol, liver microsomes from 3-methylcholanthrene-treated rats produce predominantly (+)-BaP DE-2 and much less of the other three diol epoxide isomers (56). Despite the different cell types and the overlay of BaP metabolism in the skin experiments, the mutational pattern is quite similar for BaP on mouse skin and (+)-BaP DE-2 in hamster cells in culture. In mouse skin, the proportion of G right-arrow T transversions is slightly higher (83%), and G right-arrow C transversions (13%) and G right-arrow A transitions (4%) are correspondingly lower than what was seen in the cultured cell studies.

Misincorporation by poleta at (+)-BaP DE-2 adducts fits the above mutational spectra well. In vitro reaction of (+)-BaP DE-2 with calf thymus DNA gives trans S and cis R adducts in the ratio of ~40:1 (50). Therefore, it is reasonable to assume that mutations arising at G in mammalian cells are likely to arise largely from the trans S adducts formed in multiple sites in the DNA, and the effect of cis R adducts may be ignored. Misincorporation of A, G, and T by poleta at trans S adducts would give rise to G right-arrow T, G right-arrow C, and G right-arrow A substitutions, respectively. The proportions of A, G, and T misincorporation in sequence contexts III(G) and IV(G) (calculated from the data shown in Tables II and III, respectively) are A, 76% and 58%; G, 19% and 31%; and T, 5% and 10%. When extension of the appropriate mispairs is also taken into account by comparison of the products (Vmax/Km)inc·(Vmax/Km)ext, the proportions of A, G, and T mispairs that are formed and also extended by one base beyond the lesion in context III(G) are 65%, 32%, and 3%, respectively. These relative misincorporation and bypass efficiencies coincide well with the mammalian cell and mouse skin mutational spectra. Although another Y-family DNA polymerase polkappa can also bypass BaP DE dG adducts (57), it does so in a largely error-free manner and is thus unlikely to be responsible for mutagenesis induced by these lesions (58). It is tempting to speculate that purine misincorporation opposite BaP DE adducts by error-prone poleta may play a role in generating the pattern of mutations seen in mammalian cells containing these DNA lesions.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** Work done on sabbatical leave from the Department of Chemistry, American University, Washington D. C. 20016. To whom correspondence should be addressed: Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, Bethesda, MD 20892; Tel.: 202-885-1772; Fax: 202-885-1752; E-mail: acheh@american.edu.

Published, JBC Papers in Press, January 30, 2002, DOI 10.1074/jbc.M112139200

    ABBREVIATIONS

The abbreviations used are: pol, DNA polymerase; XPV, xeroderma pigmentosum variant; PAH, polycyclic aromatic hydrocarbons; BaP, benzo[a]pyrene; DE, diol epoxide; DE-2, diol epoxide isomer with the benzylic hydroxyl group and the epoxide oxygen trans to each other (with DE-1, these groups are cis); (+)-BaP DE-2, (+)-(7R,8S,9S,10R)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene; (-)-BaP DE-2, its (-)-(7S,8R,9R,10S)-enantiomer; 8-oxo-dG, 8-oxodeoxyguanosine; dG, deoxyguanosine; HPRT, hypoxanthine-guanine phosphoribosyltransferase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Hanahan, D., and Weinberg, R. A. (2000) Cell 100, 57-70[CrossRef][Medline] [Order article via Infotrieve]
2. Cordeiro-Stone, M., Zaritskaya, L. S., Price, L. K., and Kaufmann, W. K. (1997) J. Biol. Chem. 272, 13945-13954[Abstract/Free Full Text]
3. Wood, R. D. (1999) Nature 399, 639-640[CrossRef][Medline] [Order article via Infotrieve]
4. Woodgate, R. (1999) Genes Dev. 13, 2191-2195[Free Full Text]
5. Friedberg, E. C., and Gerlach, V. L. (1999) Cell 98, 413-416[CrossRef][Medline] [Order article via Infotrieve]
6. Johnson, R. E., Washington, M. T., Prakash, S., and Prakash, L. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 12224-12226[Free Full Text]
7. Lindahl, T., and Wood, R. D. (1999) Science 286, 1897-1905[Abstract/Free Full Text]
8. Baynton, K., and Fuchs, R. P. P. (2000) Trends Biochem. Sci. 25, 74-79[CrossRef][Medline] [Order article via Infotrieve]
9. Hübscher, U., Nasheuer, H.-P., and Syväoja, J. E. (2000) Trends Biochem. Sci. 25, 143-147[CrossRef][Medline] [Order article via Infotrieve]
10. Goodman, M. F., and Tippin, B. (2000) Nat. Revs. Mol. Cell. Biol. 1, 101-109[CrossRef][Medline] [Order article via Infotrieve]
11. Livneh, Z. (2001) J. Biol. Chem. 276, 25639-25642[Free Full Text]
12. Masutani, C., Kusumoto, R., Yamada, A., Dohmae, N., Yokoi, M., Yuasa, M., Araki, M., Iwai, S., Takio, K., and Hanaoka, F. (1999) Nature 399, 700-704[CrossRef][Medline] [Order article via Infotrieve]
13. Johnson, R. E., Kondratick, C. M., Prakash, S., and Prakash, L. (1999) Science 285, 263-265[Abstract/Free Full Text]
14. Ohmori, H., Friedberg, E. C., Fuchs, R. P. P., Goodman, M. F., Hanaoka, F., Hinkle, D., Kunkel, T. A., Lawrence, C. W., Livneh, Z., Nohmi, T., Prakash, L., Prakash, S., Todo, T., Walker, G. C., Wang, Z., and Woodgate, R. (2001) Mol. Cell 8, 7-8[CrossRef][Medline] [Order article via Infotrieve]
15. Johnson, R. E., Prakash, S., and Prakash, L. (1999) Science 283, 1001-1004[Abstract/Free Full Text]
16. Masutani, C., Araki, M., Yamada, A., Kusumoto, R., Nogimori, T., Maekawa, T., Iwai, S., and Hanaoka, F. (1999) EMBO J. 18, 3491-3501[CrossRef][Medline] [Order article via Infotrieve]
17. Johnson, R. E., Washington, M. T., Prakash, S., and Prakash, L. (2000) J. Biol. Chem. 275, 7447-7450[Abstract/Free Full Text]
18. Masutani, C., Kusumoto, R., Iwai, S., and Hanaoka, F. (2000) EMBO J. 19, 3100-3109[CrossRef][Medline] [Order article via Infotrieve]
19. Vaisman, A., Masutani, C., Hanaoka, F., and Chaney, S. G. (2000) Biochemistry 39, 4575-4580[CrossRef][Medline] [Order article via Infotrieve]
20. Johnson, R. E., Haracska, L., Prakash, S., and Prakash, L. (2001) Mol. Cell. Biol. 21, 3558-3563[Abstract/Free Full Text]
21. Dipple, A., Moschel, R. C., and Bigger, C. A. H. (1984) in Chemical Carcinogens, Second Edition (Searle, C. E., ed) , American Chemical Society, Washington, D. C., ACS (Am. Chem. Soc.) Monogr. 182, 41-163
22. Thakker, D. R., Yagi, H., Levin, W., Wood, A. W., Conney, A. H., and Jerina, D. M. (1985) in Bioactivation of Foreign Compounds (Anders, M. W., ed) , pp. 177-242, Academic Press, New York, NY
23. Jerina, D. M., Lehr, R., Schaefer-Ridder, M., Yagi, H., Karle, J. M., Thakker, D. R., Wood, A. W., Lu, A. Y. H., Ryan, D., West, S., Levin, W., and Conney, A. H. (1977) in Origins of Human Cancer (Hiatt, H. , Watson, J. D. , and Winsten, I., eds) , pp. 639-658, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
24. Jerina, D. M., Yagi, H., Thakker, D. R., Sayer, J. M., van Bladeren, P. J., Lehr, R. E., Whalen, D. L., Levin, W., Chang, R. L., Wood, A. W., and Conney, A. H. (1984) in Foreign Compound Metabolism (Caldwell, J. , and Paulson, G. D., eds) , pp. 257-266, Taylor and Francis Ltd., London
25. Thakker, D. R., Levin, W., Wood, A. W., Conney, A. H., Yagi, H., and Jerina, D. M. (1988) in Drug Stereochemistry---Analytical Methods and Pharmacology (Wainer, I. W. , and Drayer, D. E., eds) , pp. 271-296, Marcel Dekker, Inc., New York, NY
26. Jerina, D. M., Sayer, J. M., Agarwal, S. K., Yagi, H., Levin, W., Wood, A. W., Conney, A. H., Pruess-Schwartz, D., Baird, W. M., Pigott, M. A., and Dipple, A. (1986) in Biological Reactive Intermediates III (Kocsis, J. J. , Jollow, D. J. , Witmer, C. M. , Nelson, J. O. , and Snyder, R., eds) , pp. 11-30, Plenum Press, New York, NY
27. Jerina, D. M., Chadha, A., Cheh, A. M., Schurdak, M. E., Wood, A. W., and Sayer, J. M. (1991) in Biological Reactive Intermediates IV. Molecular and Cellular Effects and Their Impact on Human Health (Adv. Exp. Med. Biol. 283) (Witmer, C. M. , Snyder, R. , Jollow, D. J. , Kalf, G. F. , Kocsis, J. J. , and Sipes, I. G., eds) , pp. 533-553, Plenum Press, New York, NY
28. Zhang, Y., Yuan, F., Wu, X., Rechkoblit, O., Taylor, J.-S., Geacintov, N. E., and Wang, Z. (2000) Nucleic Acids Res. 28, 4717-4724[Abstract/Free Full Text]
29. Kroth, H., Yagi, H., Sayer, J. M., Kumar, S., and Jerina, D. M. (2001) Chem. Res. Toxicol. 14, 708-719[Medline] [Order article via Infotrieve]
30. Page, J. E., Zajc, B., Oh-hara, T., Lakshman, M. K., Sayer, J. M., Jerina, D. M., and Dipple, A. (1998) Biochemistry 37, 9127-9137[CrossRef][Medline] [Order article via Infotrieve]
31. Creighton, S., Bloom, L. B., and Goodman, M. F. (1995) Methods Enzymol. 262, 232-256[Medline] [Order article via Infotrieve]
32. Matsuda, T., Bebenek, K., Masutani, C., Hanaoka, F., and Kunkel, T. A. (2000) Nature 404, 1011-1013[CrossRef][Medline] [Order article via Infotrieve]
33. Topal, M. D., and Fresco, J. S. (1976) Nature 263, 285-289[CrossRef][Medline] [Order article via Infotrieve]
34. Zhou, B. L., Pata, J. D., and Steitz, T. A. (2001) Mol. Cell 8, 427-437[CrossRef][Medline] [Order article via Infotrieve]
35. Trincao, J., Johnson, R. E., Escalante, C. R., Prakash, S., Prakash, L., and Aggarwal, A. K. (2001) Mol. Cell 8, 417-426[CrossRef][Medline] [Order article via Infotrieve]
36. Ling, H., Boudsocq, F., Woodgate, R., and Yang, W. (2001) Cell 107, 91-102[CrossRef][Medline] [Order article via Infotrieve]
37. Friedberg, E. C., Fischhaber, P. L., and Kisker, C. (2001) Cell 107, 9-12[CrossRef][Medline] [Order article via Infotrieve]
38. Cosman, M., Hingerty, B. E., Geacintov, N. E., Broyde, S., and Patel, D. J. (1995) Biochemistry 34, 15334-15350[CrossRef][Medline] [Order article via Infotrieve]
39. Feng, B., Gorin, A., Hingerty, B. E., Geacintov, N. E., Broyde, S., and Patel, D. J. (1997) Biochemistry 36, 13769-13779[CrossRef][Medline] [Order article via Infotrieve]
40. Cosman, M., de los Santos, C., Fiala, R., Hingerty, B. E., Singh, S. B., Ibanez, V., Margulis, L. A., Live, D., Geacintov, N. E., Broyde, S., and Patel, D. J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 1914-1918[Abstract/Free Full Text]
41. Ya, N.-Q., Smirnov, S., Cosman, M., Bhanot, S., Ibanez, V., and Geacintov, N. E. (1994) in Structural Biology: The State of the Art (Sarma, R. H. , and Sarma, M. H., eds) , pp. 349-366, Adenine Press, Albany, NY
42. Perlow, R. A., and Broyde, S. (2001) J. Mol. Biol. 309, 519-536[CrossRef][Medline] [Order article via Infotrieve]
43. Cosman, M., de los Santos, C., Fiala, R., Hingerty, B. E., Ibanez, V., Luna, E., Harvey, R., Geacintov, N. E., Broyde, S., and Patel, D. J. (1993) Biochemistry 32, 4145-4155[CrossRef][Medline] [Order article via Infotrieve]
44. Cosman, M., Hingerty, B. E., Luneva, N., Amin, S., Geacintov, N. E., Broyde, S., and Patel, D. J. (1996) Biochemistry 35, 9850-9863[CrossRef][Medline] [Order article via Infotrieve]
45. Kouchakdjian, M., Bodepudi, V., Shibutani, S., Eisenberg, M., Johnson, F., Grollman, A. P., and Patel, D. J. (1991) Biochemistry 30, 1403-1412[CrossRef][Medline] [Order article via Infotrieve]
46. Efrati, E., Tocco, G., Eritja, R., Wilson, S. H., and Goodman, M. F. (1999) J. Biol. Chem. 274, 15920-15926[Abstract/Free Full Text]
47. Shibutani, S., Suzuki, N., Tan, X., Johnson, F., and Grollman, A. P. (2001) Biochemistry 40, 3717-3722[CrossRef][Medline] [Order article via Infotrieve]
48. O'Handley, S. F., Sanford, D. G., Xu, R., Lester, C. C., Hingerty, B. E., Broyde, S., and Krugh, T. R. (1993) Biochemistry 32, 2481-2497[CrossRef][Medline] [Order article via Infotrieve]
49. Haracska, L., Yu, S.-L., Johnson, R. E., Prakash, L., and Prakash, S. (2000) Nat. Genet. 25, 458-461[CrossRef][Medline] [Order article via Infotrieve]
50. Sayer, J. M., Chadha, A., Agarwal, S. K., Yeh, H. J. C., Yagi, H., and Jerina, D. M. (1991) J. Org. Chem. 56, 20-29[CrossRef]
51. Johnson, R. E., Washington, M. T., Haracska, L., Prakash, S., and Prakash, L. (2000) Nature 406, 1015-1019[CrossRef][Medline] [Order article via Infotrieve]
52. Wei, S.-J. C., Chang, R. L., Hennig, E., Cui, X. X., Merkler, K. A., Wong, C.-Q., Yagi, H., Jerina, D. M., and Conney, A. H. (1994) Carcinogenesis 15, 1729-1735[Abstract/Free Full Text]
53. Wei, S.-J. C., Chang, R. L., Bhachech, N., Cui, X. X., Merkler, K. A., Wong, C.-Q., Hennig, E., Yagi, H., Jerina, D. M., and Conney, A. H. (1993) Cancer Res. 53, 3294-3301[Abstract/Free Full Text]
54. Schiltz, M., Cui, X. X., Lu, Y.-P., Yagi, H., Jerina, D. M., Zdzienicka, M. Z., Chang, R. L., Conney, A. H., and Wei, S.-J. C. (1999) Carcinogenesis 20, 2279-2285[Abstract/Free Full Text]
55. Wei, S.-J. C., Chang, R. L., Merkler, K. A., Gwynne, M., Cui, X. X., Murthy, B., Huang, M.-T., Xie, J.-G., Lu, Y.-P., Lou, Y.-R., Jerina, D. M., and Conney, A. H. (1999) Carcinogenesis 20, 1689-1696[Abstract/Free Full Text]
56. Thakker, D. R., Yagi, H., Akagi, H., Koreeda, M., Lu, A. Y. H., Levin, W., Wood, A. W., Conney, A. H., and Jerina, D. M. (1977) Chem.-Biol. Interact. 16, 281-300[CrossRef][Medline] [Order article via Infotrieve]
57. Zhang, Y., Yuan, F., Wu, X., Wang, M., Rechkoblit, O., Taylor, J.-S., Geacintov, N. E., and Wang, Z. (2000) Nucleic Acids Res. 28, 4138-4146[Abstract/Free Full Text]
58. Ogi, T., Mimura, J., Hikida, M., Fujimoto, H., Fujii-Kuriyama, Y., and Ohmori, H. (2001) Genes to Cells 6, 943-953[Abstract]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles: